BOSTON (LifeSiteNews) — Embattled Boston Children’s Hospital (BCH) is once again snagging headlines for all the wrong reasons after the head of its gender clinic was seen admitting in a recently resurfaced video that rates of gender dysphoria have “skyrocketed” and that transgender drug regimens can damage fertility.
Pediatric endocrinologist and director of Boston Children’s Hospital’s GeMS (Gender Management Service) program Jeremi Carswell, MD, made the remarks during a 2020 Advancing Excellence in Transgender Health (AETH) conference.
In a recorded webinar called “Puberty Blockers and Hormone Therapy for Gender Diverse Youth and Adolescents” on the National LGBTQIA+ Health Education Center website, Dr. Carswell explained that “the number of adolescents who have been coming into gender programs over the last several years has really kind of skyrocketed,” adding that puberty-blocking drugs are being “given out a lot like candy.”
Though promoting transgender treatment as “great” and “helpful,” Carswell cautioned that “you need to have the conversation about fertility.”
According to the gender clinic director, medication “that shuts down your estrogen or shuts down testosterone entirely” will cause its recipient to “stop … producing sperm or eggs.”